Medical microbiology studies illnesses caused by microorganisms, including viruses, bacteria, fungi, algae, and protozoa. Antimicrobial agents inhibit growth, while micro-biostatic agents prevent pathogen growth and aid defense mechanisms. Germicides, categorized by mode of action and administration, may show selective toxicity. They have the ability to destroy viruses, bacteria, algae, or fungi as viricides, bacteriocides, or fungicides. The goal of this study is to determine whether extracts from the plants Lauki (Lagenaria siceraria) and Chhota Chirayta (Swertia chirayita) have antimicrobial qualities. The traditional therapeutic use of these two plants dates back a long way and their possible anti-microbial qualities are highly intriguing when it comes to fighting infectious diseases. The purpose of the study is to evaluate and compare the anti-microbial activity of Lauki and Chhota Chirayta extracts against a variety of harmful bacteria both in vitro and in vivo. The outcomes of the in-vitro and in-vivo studies will offer insightful information about the anti-microbial properties of Lauki and Chhota Chirayta extracts, illuminating potential uses in complementary and alternative medicine. The results could lead to the creation of new treatment alternatives for infectious disorders, especially in areas where traditional herbal medicines are extensively used. This study deserves more investigation since it shows promise for using natural plant extracts as possible sources of anti-microbial chemicals in the fight against infectious diseases.
This work is licensed under a Creative Commons Attribution 4.0 International License.
You may also start an advanced similarity search for this article.